Literature DB >> 30789293

Measuring DNA Copy Number Variation Using High-Density Methylation Microarrays.

Soonweng Cho1, Hyun-Seok Kim2, Martha A Zeiger3, Christopher B Umbricht4, Leslie M Cope5.   

Abstract

Genetic and epigenetic changes drive carcinogenesis, and their integrated analysis provides insights into mechanisms of cancer development. Computational methods have been developed to measure copy number variation (CNV) from methylation array data, including ChAMP-CNV, CN450K, and, introduced here, Epicopy. Using paired single nucleotide polymorphism (SNP) and methylation array data from the public The Cancer Genome Atlas repository, we optimized CNV calling and benchmarked the performance of these methods. We optimized the thresholds of all three methods and showed comparable performance across methods. Using Epicopy as a representative analysis of Illumina450K array, we show that Illumina450K-derived CNV methods achieve a sensitivity of 0.7 and a positive predictive value of 0.75 in identifying CNVs, which is similar to results achieved when comparing competing SNP microarray platforms with each other.

Entities:  

Keywords:  CNV; TCGA; copy number variation; methylation microarray; microarray

Mesh:

Year:  2019        PMID: 30789293      PMCID: PMC6479247          DOI: 10.1089/cmb.2018.0143

Source DB:  PubMed          Journal:  J Comput Biol        ISSN: 1066-5277            Impact factor:   1.479


  20 in total

1.  Circular binary segmentation for the analysis of array-based DNA copy number data.

Authors:  Adam B Olshen; E S Venkatraman; Robert Lucito; Michael Wigler
Journal:  Biostatistics       Date:  2004-10       Impact factor: 5.899

Review 2.  Epigenetics in cancer.

Authors:  Manel Esteller
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

3.  Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants.

Authors:  Dalila Pinto; Katayoon Darvishi; Xinghua Shi; Diana Rajan; Diane Rigler; Tom Fitzgerald; Anath C Lionel; Bhooma Thiruvahindrapuram; Jeffrey R Macdonald; Ryan Mills; Aparna Prasad; Kristin Noonan; Susan Gribble; Elena Prigmore; Patricia K Donahoe; Richard S Smith; Ji Hyeon Park; Matthew E Hurles; Nigel P Carter; Charles Lee; Stephen W Scherer; Lars Feuk
Journal:  Nat Biotechnol       Date:  2011-05-08       Impact factor: 54.908

4.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Authors:  Roel G W Verhaak; Katherine A Hoadley; Elizabeth Purdom; Victoria Wang; Yuan Qi; Matthew D Wilkerson; C Ryan Miller; Li Ding; Todd Golub; Jill P Mesirov; Gabriele Alexe; Michael Lawrence; Michael O'Kelly; Pablo Tamayo; Barbara A Weir; Stacey Gabriel; Wendy Winckler; Supriya Gupta; Lakshmi Jakkula; Heidi S Feiler; J Graeme Hodgson; C David James; Jann N Sarkaria; Cameron Brennan; Ari Kahn; Paul T Spellman; Richard K Wilson; Terence P Speed; Joe W Gray; Matthew Meyerson; Gad Getz; Charles M Perou; D Neil Hayes
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

5.  Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients.

Authors:  Marco Capezzone; Silvia Cantara; Stefania Marchisotta; Sebastiano Filetti; Maria Margherita De Santi; Benedetta Rossi; Giuseppe Ronga; Cosimo Durante; Furio Pacini
Journal:  J Clin Endocrinol Metab       Date:  2008-07-29       Impact factor: 5.958

6.  The pitfalls of platform comparison: DNA copy number array technologies assessed.

Authors:  Christina Curtis; Andy G Lynch; Mark J Dunning; Inmaculada Spiteri; John C Marioni; James Hadfield; Suet-Feung Chin; James D Brenton; Simon Tavaré; Carlos Caldas
Journal:  BMC Genomics       Date:  2009-12-08       Impact factor: 3.969

Review 7.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

8.  pROC: an open-source package for R and S+ to analyze and compare ROC curves.

Authors:  Xavier Robin; Natacha Turck; Alexandre Hainard; Natalia Tiberti; Frédérique Lisacek; Jean-Charles Sanchez; Markus Müller
Journal:  BMC Bioinformatics       Date:  2011-03-17       Impact factor: 3.307

9.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.

Authors:  Craig H Mermel; Steven E Schumacher; Barbara Hill; Matthew L Meyerson; Rameen Beroukhim; Gad Getz
Journal:  Genome Biol       Date:  2011-04-28       Impact factor: 13.583

10.  Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors.

Authors:  L O Baumbusch; J Aarøe; F E Johansen; J Hicks; H Sun; L Bruhn; K Gunderson; B Naume; V N Kristensen; K Liestøl; A-L Børresen-Dale; O C Lingjaerde
Journal:  BMC Genomics       Date:  2008-08-08       Impact factor: 3.969

View more
  5 in total

1.  DNA Copy Number Variation Associated with Anti-tumour Necrosis Factor Drug Response and Paradoxical Psoriasiform Reactions in Patients with Moderate-to-severe Psoriasis.

Authors:  Ancor Sanz-Garcia; Alejandra Reolid; Laura H Fisas; Ester Muñoz-Aceituno; Mar Llamas-Velasco; Antonio Sahuquillo-Torralba; Rafael Botella-Estrada; Jorge García-Martínez; Raquel Navarro; Esteban Daudén; Francisco Abad-Santos; Maria C Ovejero-Benito
Journal:  Acta Derm Venereol       Date:  2021-05-04       Impact factor: 3.875

2.  DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome.

Authors:  L C Schenkel; E Aref-Eshghi; K Rooney; J Kerkhof; M A Levy; H McConkey; R C Rogers; K Phelan; S M Sarasua; L Jain; R Pauly; L Boccuto; B DuPont; G Cappuccio; N Brunetti-Pierri; C E Schwartz; B Sadikovic
Journal:  Clin Epigenetics       Date:  2021-01-06       Impact factor: 6.551

Review 3.  DNA methylation as a diagnostic tool.

Authors:  Kristyn Galbraith; Matija Snuderl
Journal:  Acta Neuropathol Commun       Date:  2022-05-08       Impact factor: 7.801

4.  MethylMasteR: A Comparison and Customization of Methylation-Based Copy Number Variation Calling Software in Cancers Harboring Large Scale Chromosomal Deletions.

Authors:  Michael P Mariani; Jennifer A Chen; Ze Zhang; Steven C Pike; Lucas A Salas
Journal:  Front Bioinform       Date:  2022-04-12

Review 5.  DNA Methylation Episignatures in Neurodevelopmental Disorders Associated with Large Structural Copy Number Variants: Clinical Implications.

Authors:  Kathleen Rooney; Bekim Sadikovic
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.